(Q41094530)

English

Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere

scientific article published on January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

Europe PubMed Central

Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

Kiso Y

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

235-244

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Rational design and synthesis of a novel class of active site-targeted HIV protease inhibitors containing a hydroxymethylcarbonyl isostere. Use of phenylnorstatine or allophenylnorstatine as a transition-state mimic

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Peptide substrates and inhibitors of the HIV-1 protease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Constructing proteins by dovetailing unprotected synthetic peptides: backbone-engineered HIV protease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Rational design of peptide-based HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Effect of hydroxyl group configuration in hydroxyethylamine dipeptide isosteres on HIV protease inhibition. Evidence for multiple binding modes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Kynostatin (KNI)-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Impaired infectivity of HIV-1 after a single point mutation in the POL gene to escape the effect of a protease inhibitor in vitro

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Design and synthesis of HIV protease inhibitors containing allophenylnorstatine as a transition-state mimic.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Solution structure of HIV-1 protease-allophenylnorstatine derivative inhibitor complex obtained from molecular dynamics simulation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Comparison of a new orally potent tripeptide HIV-1 protease inhibitor (anti-AIDS drug) based on pharmacokinetic characteristics in rats after intravenous and intraduodenal administrations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Pharmacokinetic study of a tripeptide HIV-1 protease inhibitor, KNI-174, in rats after intravenous and intraduodenal administrations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0282%281996%2940%3A2%3C235%3A%3AAID-BIP3%3E3.0.CO%3B2-X

21 January 2018

Identifiers

10.1002/(SICI)1097-0282(1996)40:2<235::AID-BIP3>3.0.CO;2-X

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41094530&oldid=2093448947"